东曜药业-B(01875.HK)拟8月12日举行董事会会议批准中期业绩

Core Viewpoint - Dongyao Pharmaceutical-B (01875.HK) has announced a board meeting scheduled for August 12, 2025, to consider and approve the interim results for the six months ending June 30, 2025, along with other matters [1] Summary by Category - Company Announcement - The company will hold a board meeting on August 12, 2025, to discuss the interim performance [1] - The meeting will focus on the financial results for the six months ending June 30, 2025 [1] - Other unspecified matters will also be addressed during the meeting [1]